Vertex wins FDA approval for non-opioid pain drug, setting stage for closely watched rollout
Vertex Pharmaceuticals on Thursday won approval from the Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a product that has simultaneously sparked high hopes and mixed opinions among physicians and market analysts.
FDA approves new pain drug Journavx as opioid alternative
Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.
The FDA is overhauling food labels to redefine "'healthy," focusing on redefining terms and introducing new front-of-package ...
In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr ...
RFK Jr. said in Wednesday's confirmation hearing that he wants to combat food dyes. 'Crunchy moms' finally feel seen.
Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...
4don MSN
The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...
Dr. Dorothy Fink, the acting secretary for the Department of Health and Human Services under President Donald Trump, has ...
But experts say there may be a number of opportunities for lab-grown meat under a second Trump administration. Industry ...
The FDA announced the changes in a “ prevention strategy ” to keep fresh and frozen berries from being contaminated with ...
The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback